More FDA Warning Letter to Drug Manufacturing Facility in Thailand
More Air-Tightness of Cleanrooms & Containment Solutions: VDI 2083 Part 19 Updated
More EMA/FDA joint Q&As on Quality and GMP aspects of Breakthrough Therapy Applications
More Where to find GDP Certificates and Wholesale Distributor Authorisations
More Checklist for Implementation of GDP Principles - Part 5: Operations
More Improving Registration and Reporting Summary Results Information for Clinical Trials
More Master Protocols for Drug and Biological Product Development
More Swissmedic publishes Technical Interpretation on Shipment under Quarantine
More APIs in Brazil: how to register and obtain the GMP certificate
More FDA Warning Letter Defines Minimum Criteria for Process Validation
More Is it Acceptable to Mix Extract-Batches in order to Improve Batch-to-Batch Consistency?
More Non-compliance Report (EudraGMDP): Cross-Contamination Risk at Indian pharmaceutical Company